P724 VIROLOGICAL RESPONSE IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION RECEIVING FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IS UNAFFECTED BY RIBAVIRIN DOSE REDUCTION

2014 ◽  
Vol 60 (1) ◽  
pp. S311
Author(s):  
T. Asselah ◽  
D.M. Jensen ◽  
G.R. Foster ◽  
M.S. Sulkowski ◽  
D. Ouzan ◽  
...  
Keyword(s):  
Dose Reduction ◽  
Virological Response ◽  
Pegylated Interferon ◽  
Genotype 1 ◽  
Hcv Genotype ◽  
Treatment Naïve ◽  
Hcv Genotype 1 ◽  
Chronic Hcv

scholarly journals Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials

2016 ◽  
Vol 15 (3) ◽  
pp. 333-349 ◽  
Author(s):  
Donald M. Jensen ◽  
Tarik Asselah ◽  
Douglas Dieterich ◽  
Graham R. Foster ◽  
Mark S. Sulkowski ◽  
...  
Keyword(s):  
Pegylated Interferon ◽  
Pooled Analysis ◽  
Genotype 1 ◽  
Phase 3 ◽  
Two Phase ◽  
Hcv Genotype ◽  
Treatment Naïve ◽  
Hcv Genotype 1

1413 SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR TREATMENT OF CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAÏVE PATIENTS: RESULTS FROM QUEST-2, A PHASE III TRIAL

2013 ◽  
Vol 58 ◽  
pp. S568 ◽  
Author(s):  
M. Manns ◽  
P. Marcellin ◽  
F.P. Fred Poordad ◽  
E. Stanislau Affonso de Araujo ◽  
M. Buti ◽  
...  
Keyword(s):  
Phase Iii ◽  
Genotype 1 ◽  
Phase Iii Trial ◽  
Hcv Genotype ◽  
Treatment Naïve ◽  
Hcv Genotype 1 ◽  
Chronic Hcv
Sign in / Sign up

Export Citation Format

Share Document